Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Study May Lead to Parkinson's Treatment

July 9, 2010 8:36 am | News | Comments

Endometrial stem cells injected into the brains of mice with a laboratory-induced form of Parkinson's disease appeared to take over the functioning of brain cells eradicated by the disease.

TOPICS:

Immobilized Enzymes

July 9, 2010 8:22 am | Drug Discovery & Development | Product Releases | Comments

Available from G-Biosciences are immobilized papain, ficin, and pepsin. These enzymes, provided in sizes of 5mL resins, are used to cleave IgG antibodies near the hinge region.

TOPICS:

Cell Culture Service

July 9, 2010 8:16 am | Product Releases | Comments

CCS Cell Culture Service has established a new technology which is now offered as a custom service to clients within drug discovery industries.

TOPICS:
Advertisement

eVol Snags R & D 100 Award

July 9, 2010 8:13 am | News | Comments

eVol the world’s first automated analytical syringe created and manufactured by SGE Analytical Science, has been selected as a 2010 R&D100 Award winner.

TOPICS:

Infinity Purchases Rights to Intellikine Drug Candidates

July 9, 2010 8:07 am | News | Comments

Infinity Pharmaceuticals, Inc.,  announced an agreement under which Infinity obtained global development and commercialization rights to Intellikine's portfolio of inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K).

TOPICS:

2010 R & D 100 Award Winners

July 9, 2010 8:00 am | News | Comments

The editors of R&D Magazine have announced the winners of the 48th Annual R&D 100 Awards, which salute the 100 most technologically significant products introduced into the marketplace over the past year.

TOPICS:

Researchers Find Shortcut to Skipped Polyenes

July 9, 2010 7:49 am | News | Comments

Scientists from The Scripps Research Institute have created a novel technique that for the first time will allow the efficient production of a molecular structure that is common to a vast array of natural molecules.

TOPICS:

CoDa Releases Positive Results From Phase 2 Study

July 9, 2010 7:23 am | News | Comments

CoDa Therapeutics, Inc. announced positive results from its Phase 2 NOVEL Study of NEXAGON in patients with chronic venous leg ulcers.

TOPICS:
Advertisement

BOTOX Licensed to Treat Chronic Migraine

July 9, 2010 7:18 am | News | Comments

Allergan has announced that BOTOX (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine—headaches on at least 15 days per month of which at least 8 days are with migraine.

TOPICS:

Cancer Stem Cells Vary From Tumor to Tumor

July 9, 2010 7:07 am | News | Comments

Cancer stem cells have enticed scientists because of the potential to provide more durable and widespread cancer cures by identifying and targeting the tumor’s most voracious cells.

TOPICS:

GSK Diabetes Drug Target of Exhaustive FDA Review

July 9, 2010 7:02 am | by Matthew Perrone | News | Comments

A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug.

TOPICS:

Newly Discovered Antibodies Stop Most HIV Strains

July 9, 2010 6:27 am | News | Comments

Scientists have discovered two potent human antibodies that can stop more than 90% of known global HIV strains from infecting human cells in the laboratory, possibly leading to improved vaccines to prevent or treat HIV infection.

TOPICS:

Sales Crumble Amidst New Recall

July 9, 2010 6:15 am | News | Comments

Sales of Johnson & Johnson pain relievers are collapsing as a string of recalls appears to have made consumers wary of once-sterling brands such as Tylenol and Motrin.

TOPICS:

EMEA Reviewing Safety of Avandia

July 9, 2010 6:02 am | News | Comments

The European agency that evaluates medicine said it will review the safety of the diabetes drug Avandia following research suggesting it is linked to a higher risk of heart problems, strokes and deaths in older adults.

TOPICS:

Fluorescence Imaging of Cranial Vasculature in Live Animals

July 8, 2010 10:32 am | by Deepak Sharma, PhD, Senior Product Manager, Photometrics, Tuscon, Ariz. | Articles | Comments

Radiation therapy is one of the most successful treatments for malignant tumors. In addition to causing tumor death it also weakens and collapses the rapidly forming vasculature around the tumor.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading